Evaric Pharmaceuticals Inc.

FDA Regulatory Profile

Evaric Pharmaceuticals Inc. appears in FDA public data with 1 recall, 0 510(k) clearances, 2 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0061-2025, Class II) was initiated on November 15, 2024.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
2
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0061-2025Class IILisinopril Tablets, USP 10 mg, 90 tablets per bottle, Rx Only, Distributed by: Walmart, Bentonville,November 15, 2024